Legal Representation
Attorney
Christopher N. Bolinger
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 5, 2007 | MAB1 | O | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | Loading... |
| Apr 5, 2007 | MAB1 | O | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | Loading... |
| Apr 3, 2007 | I | PAPER RECEIVED | Loading... | |
| Apr 3, 2007 | ABN1 | S | ABANDONMENT - EXPRESS MAILED | Loading... |
| Apr 3, 2007 | I | PAPER RECEIVED | Loading... | |
| Apr 3, 2007 | ABN1 | S | ABANDONMENT - EXPRESS MAILED | Loading... |
| Oct 3, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 3, 2006 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 11, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 11, 2006 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 21, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jun 21, 2006 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| May 24, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 24, 2006 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| May 12, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 12, 2006 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 11, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 11, 2006 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 10, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 10, 2006 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Dec 20, 2005 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | Loading... |
| Dec 20, 2005 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations namely, cholesterol preparations, insomnia preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005